Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2M Buy
102,817
+3,007
+3% +$1.03M 3.03% 10
2026
Q1
$35.1M Sell
99,810
-3,739
-4% -$1.33M 3.22% 11
2025
Q4
$33.9M Sell
103,549
-2,682
-3% -$851K 3.05% 11
2025
Q3
$30M Buy
106,231
+4,633
+5% +$1.34M 2.78% 11
2025
Q2
$28.4M Buy
101,598
+4,284
+4% +$1.21M 2.87% 13
2025
Q1
$30.3M Buy
97,314
+4,292
+5% +$1.27M 3.35% 8
2024
Q4
$24.2M Buy
93,022
+45,573
+96% +$13.5M 2.65% 14
2024
Q3
$15.3M Buy
47,449
+2,381
+5% +$779K 1.7% 25
2024
Q2
$14.1M Buy
45,068
+3,845
+9% +$1.13M 1.68% 25
2024
Q1
$11.7M Sell
41,223
-937
-2% -$274K 1.4% 34
2023
Q4
$12.1M Buy
42,160
+140
+0.3% +$38.1K 1.55% 28
2023
Q3
$11.3M Sell
42,020
-6,130
-13% -$1.53M 1.61% 25
2023
Q2
$10.7M Buy
48,150
+2,059
+4% +$478K 1.47% 30
2023
Q1
$11.1M Buy
46,091
+2,622
+6% +$644K 1.61% 27
2022
Q4
$11.4M Sell
43,469
-15,425
-26% -$4.13M 1.71% 23
2022
Q3
$13.3M Buy
58,894
+690
+1% +$167K 2.18% 17
2022
Q2
$14.2M Sell
58,204
-496
-0.8% -$122K 2.18% 16
2022
Q1
$14.2M Buy
58,700
+4,878
+9% +$1.12M 1.91% 17
2021
Q4
$12.1M Buy
53,822
+22,400
+71% +$4.73M 1.58% 27
2021
Q3
$6.68M Buy
31,422
+3,573
+13% +$822K 0.94% 39
2021
Q2
$6.79M Buy
27,849
+11,216
+67% +$2.76M 0.98% 38
2021
Q1
$4.14M Buy
+16,633
New +$3.97M 0.62% 45
2017
Q1
Sell
-3,924
Closed -$574K 68
2016
Q4
$574K Hold
3,924
0.1% 56
2016
Q3
$655K Buy
+3,924
New +$664K 0.12% 54

Other funds holding AMGN

Matrix Asset Advisors's AMGN Position: Q2 2026 in Review

Matrix Asset Advisors increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $1.03M and bringing the position to 102,817 shares worth $37.2M. The position accounts for 3.03% of the portfolio, ranked #10.

Matrix Asset Advisors first reported a position in AMGN in Q3 2016 and has held it in 24 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Matrix Asset Advisors held 102,817 shares of Amgen worth $37.2M as of Q2 2026.
  • Matrix Asset Advisors bought 3,007 Amgen shares in Q2 2026, an estimated $1.03M.
  • Amgen made up 3.03% of Matrix Asset Advisors's portfolio in Q2 2026, its #10 holding.
  • Matrix Asset Advisors first reported a position in Amgen in Q3 2016 and has held it in 24 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Matrix Asset Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.